Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection

Published:2014-11-11 Issue:7 Volume:50 Page:785-794
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Yamada Ryoko, ,Hiramatsu Naoki,Oze Tsugiko,Morishita Naoki,Harada Naoki,Yakushijin Takayuki,Iio Sadaharu,Doi Yoshinori,Yamada Akira,Kaneko Akira,Hagiwara Hideki,Mita Eiji,Oshita Masahide,Itoh Toshifumi,Fukui Hiroyuki,Hijioka Taizo,Katayama Kazuhiro,Tamura Shinji,Yoshihara Harumasa,Imai Yasuharu,Kato Michio,Miyagi Takuya,Yoshida Yuichi,Tatsumi Tomohide,Kasahara Akinori,Hamasaki Toshimitsu,Hayashi Norio,Takehara Tetsuo

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-014-1010-7.pdf

Reference28 articles.

1. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43(2 Suppl 1):S173–81.

2. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335–52.

3. Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45(4):1056–75.

4. Sherman M. Epidemiology of hepatocellular carcinoma. Oncology. 2010;78(Suppl 1):7–10.

5. Umemura T, Ichijo T, Yoshizawa K, et al. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol. 2009;44(Suppl 19):102–7.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy;Hepatology Research;2024-02-07

2. VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response;Journal of Medical Ultrasonics;2023-12-26

3. Construction of a Nomogram to Predict Overall Survival in Patients with Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study;Cancers;2023-11-07

4. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study;BMC Gastroenterology;2023-06-13

5. Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients;World Journal of Meta-Analysis;2022-06-28